Metastasis: A primer for dermatologists

Dermatologic Surgery

Volumn 22, Issue 3, 1996, Pages 228-233

  Brodland, David G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ADHESION; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; TISSUE SPECIFICITY;

EID: 0029968422     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1996.tb00313.x     Document Type: Article

References (47)

1. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980;283:239-46.
2. Brodland DG, Zitelli JA. Mechanisms of metastasis. J Am Acad Dermatol 1992;27:1-8.
3. Behrens J, Frixen U, Schipper J, Weidner M, Birchmeier, W. Cell adhesion in invasion and metastasis. Semin Cell Biol 1992;3:169-78.
4. Pandolfi F, Trentin L, Boyle LA, Stamenkovic I. Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes. Cancer 1992,69:1165-73.
5. Weiss L, Ward PM. Cell detachment and metastasis. Cancer Metastasis Rev 1983;2:111-27.
6. Lester BR, McCarthy JB. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev 1992;11:31-44.
7. Rodeck U, Becker D, Herlyn M. Basic fibroblast growth factor in human melanoma. Cancer Cells 1991;3:308-11.
8. Kerbel RS. Expression of multi-cyrokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Am J Pathol 1992,141:519-24.
9. Liotta LA: Tumor invasion and metastases: role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 1986;46: 1-7.
10. Wewer UM, Taraboletti G, Sobel ME, et al. Role of laminin receptor in tumor cell migration. Cancer Res 1987;47:5691-8.
11. Zetter BR. The cellular basis of site-specific tumor metastasis. N Engl J Med 1990;332:605-12.
12. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986;233:467-70.
13. Liotta LA, Mandler R, Murano G, et al. Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 1986;83:3302-6.
14. Hendrix MJ, Seftor EA, Chu Y, Seftor RE. Coexpression of vimentin and keratins by human melanoma tumor cells: Correlation with invasive and metastatic potential. J Natl Cancer Inst 1992; 84:165-74.
15. Taraboletti G, Roberts D, Liotta L: Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. Cell Biol 1987;105:2409-15.
16. Khokha R, Zimmer MJ, Graham CH, Lala PK, et al. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 1992;94:1017-22.
17. Südhoff T, Schneider W. Fibrinolytic mechanisms in tumor growth and spreading. Clin Invest 1992;70:631-6.
18. Reed JA, McNutt S, Prieto VG, et al. Expression of transforming growth factor-β2 in malignant melanoma correlates with the depth of tumor invasion. Am J Pathol 1994;145:97-104.
19. Nabi IR, Watanabe H, Raz A. Autocrine motility factor and its receptor: Role in cell locomotion and metastasis. Cancer Metastasis Rev 1992;11:5-20.
20. Kramer RH, Vu M, Cheng Y, Ramos DM. Integrin expressions in malignant melanoma. Cancer Metastasis Rev 1991;10:49-59.
21. Lubach D, Rautenfeld, D, Kaiser HE. The possible role of the initial lymph vessels of the skin during metastasis of malignant tumors. In Vivo 1992;6:443-50.
22. Weidner N, Folkman J, Pozza F, Bevilacqua P, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84: 1875-87.
23. Vacca A, Ribatti D, Roncali L, Lospalluti M, et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993;72: 455-61.
24. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79:185-8.
25. O'Reilly MS, Holmgren L, Shing Y, Chen C. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
26. McCarthy JB, Basara ML, Palm SL, et al. The role of cell adhesion proteins (laminin and fibronection) in the movement of malignant and metastatic cells. Cancer Metastasis Rev 1985;4:125-52.
27. Juliano RL. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochem Biophys Acta 1987;907:261-78.
28. Liotta LA, Tryggvason K, Garbisa S, et al. Metastatic potential correlates with enzmatic degradation of basement membrane collagen. Nature 1980;284:67-8.
29. Fidler IJ, Balch CM. The biology of cancer metastasis and implications for therapy. Curr Probl Surg 1987;24:129-209
30. Salsbury AJ. The significance of the circulating cancer cell. Cancer Treat Rev 1975;2:55-72.
31. 125I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970;45:773-82.
32. Kreider JW, Barlett GL. Is there a host response to metastasis? Prog Clin Biol Res 1986;212:61-75.
33. Arch R, Wirth K, Hofmann M, Ponta H. Participation in normal immune responses of a metastasis-induing splice variant of CD44. Science 1992;257:682-5.
34. Fidler IJ, Bucana C. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Cancer Res 1977;37:3945-56.
35. Nicolson GL. Organ specificity of tumor metastasis: Role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 1988;7:143-88.
36. Wagner HE, Thomas P, Wolf BC, et al. Inhibition of sialic acid incorporation prevents hepatic metastases. Arch Surg 1990;125: 351-4.
37. del Regato JA. Pathways of metastatic spread of malignant tumors. Semin Oncol 1977;4:33-8.
38. Leon P, Daly JM, Synnestvedt M, Schultz DJ, et al. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 1991;126:1461-8.
39. Liotta LA, Kohn E. Cancer invasion and metastases. JAMA 1990; 263:1123-6.
40. Whitesell PL, Peters SG. Pulmonary manifestations of extrathoracic malignant lesions. Mayo Clin Proc 1993;68:483-91.
41. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1985;1:571-3.
42. Hujanen ES, Terranova VP. Migration of tumor cells to organderived chemoattractants. Cancer Res 1985;45:3517-21.
43. Auerbach R, Lu WC, Pardon E, et al. Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res 1987; 47:1492-6.
44. Ruiz P, Dunon D, Sonnenberg A, Imhof BA. Suppression of mouse melanoma metastasis by EA-I: a monoclonal antibody specific for a6 integrins. Cell Adhesion and Communication 1993; 1:67-81.
45. Taraboletti G, Belotti D, Giavazzi R, Sobel ME, Castronovo V. Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. J Natl Cancer Inst 1993;85:235-40.
46. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
47. Nguyen M, Watanabe H, Budson AE, Richie JP, et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994;86:356-61.